Tamayo-Orozco JA

Language: Spanish
References: 12
Page: 520-524
PDF size: 36.51 Kb.

ABSTRACT

Chronic kidney disease coverage in Mexico is regulated under constitutional mandate approved by the Congress in 2004 through the National Commission for Social Health Protection (CNPSS) it does so under the Popular Health Insurance (SP) following the rules of an universal health services catalog (CAUSES) based upon budget in a per capita basis or in more expensive clinical situations like dialysis and transplantation, through a specific fund for catastrophic expenses. SP operates through credited services by the Intergated Quality System SICalidad mainly represented by the already existing network of our public health system. Mexican public health policy to care for chronic renal disease will involve screening of high risk populations, definition of remnant kidney parenchyma function, deterioration factors, early and strict intervention regimes, early identification of the advanced chronic kidney insufficiency, training and optimal selection of the dialysis or transplantation procedures when required. Competirc is actively involved in the design of the clinical guidelines as well as the accreditation standards for establishments for dialysis and transplantation.

REFERENCES

1. Reforma al artículo 4° constitucional aprobada por el H. Congreso de la Unión. Diario Oficial de la Federación del 27 de febrero de 2004.

2. Reforma a la Ley General de Salud. Diario oficial de la Federación del 19 de junio de 2007.

3. Secretaría de Salud. Reglamento de la Ley General de Salud en Materia de de Protección Social en Salud. Diario Oficial de la Federación del 5 de abril de 2004.

4. http://www.seguro-popular.salud.gob.mx/contenidos/red_prestadores/ red_causes/red_causes_inicio.html

5. http://www.seguro-popular.salud.gob.mx/contenidos/cobertura.html

6. Secretaría de Salud. Reglamento interior del Consejo de Salubridad General. (primera sección). Diario Oficial de la Federación del 30 de octubre de 2001.

7. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, et al. Chronic kidney disease as a global public health problem: Approaches and initiatives. A position statement from kidney disease improving global outcomes. Kidney Int 2007;72:247-259.

8. National Kidney Foundation. K/DOQUI clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis 2002;39(suppl 1):S1-S266.

9. Paniagua R, Ramos A, Fabián R, Lagunas J, Amato D. Chronic kidney disease and dialysis in Mexico. Perit Dial Int 2007;27:405-409.

10. García-García G, Monteón-Ramos JF, García-Bejarano H, Gómez-Navarro B, Reyes IH, Lomeli AM, et al. Renal replacement therapy among disadvantaged populations in Mexico: A report from the Jalisco Dialysis and Transplant Registry (REDTJAL). Kidney Int 2005;97(suppl):S58-S61.

11. Cueto-Manzano AM, Cortés-Sanabria L, Martínez-Ramírez HR, Rojas-Campos E, Barragán G, Alfaro G, et al. Detection of early nephropathy in Mexican patients with type 2 diabetes mellitus. Kidney Int 2005;68(suppl):S40-S45.

12. Keith D, Nicholls G, Guillion C. Longitudinal follow up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Int Med 2004;164:659-663.